Greco Theresa 4

What Happened Theresa Greco, Chief Commercial Officer of OptimizeRx (OPRX), had 1,793 shares withheld by the company on May 15, 2026 to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs). The withholding occurred in two lots: 914 shares and 879 shares, each withheld at a per-share value of $5.21, totaling approximately $9,342. These withholdings are treated as dispositions under Section 16 (transaction code F) and are routine tax-related transactions rather than open-market sales.

Key Details

• Transaction date: May 15, 2026
• Withheld lots: 914 shares @ $5.21 = $4,762; 879 shares @ $5.21 = $4,580
• Total withheld: 1,793 shares for approximately $9,342
• Transaction code: F (shares withheld to satisfy tax withholding on vesting RSUs)
• Shares owned after transaction: Not disclosed in the provided filing
• Filing timeliness: Report filed May 18, 2026 for a May 15 transaction (filed timely)
• Footnote: The filing notes the shares were withheld by the issuer upon RSU vesting to satisfy the Reporting Person's tax withholding obligations; such withholding is treated as a disposition under Section 16.

Context Tax-withholdings on vested RSUs are common and considered administrative dispositions (not necessarily a signal of insider sentiment). The filing also includes a standard remark clarifying that it is not an admission of beneficial ownership or an assertion that the filing was legally required.